NCT01426399 Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01423487 Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea Status WITHDRAWN Phase NA
NCT01422746 Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess Status RECRUITING Phase EARLY_PHASE1
NCT01400191 The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1 Status COMPLETED Phase PHASE4
NCT01381900 A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea Status COMPLETED Phase PHASE3
NCT01370707 A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients Status COMPLETED Phase PHASE3
NCT01368081 Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01367054 Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg Status UNKNOWN Phase NA
NCT01366391 Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome Status UNKNOWN Phase PHASE4
NCT01365091 Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil Status COMPLETED Phase PHASE1
NCT01357135 An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201) Status COMPLETED Phase N/A
NCT01352026 Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH) Status WITHDRAWN Phase PHASE2